1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research (SBIR) Program is sponsored by U.S. Department of Health and Human Services (HHS) / Centers for Disease Control and Prevention (CDC). The SBIR program provides funding for domestic small business concerns to engage in relevant Federal Research/Research and Development (R/R&D) with the potential for commercialization and public benefit.
This includes developing technological innovations related to public health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
About the Small Business Innovation Research Program | Tech and Innovation | CDC Skip directly to site content About the Small Business Innovation Research Program The Small Business Innovation Research (SBIR) program is a set-aside program (3.
2% of an agency's extramural budget) for domestic small business concerns to engage in relevant Federal Research/Research and Development (R/R&D) with the potential for commercialization and public benefit. The SBIR program was established under the Small Business Innovation Development Act of 1982 (P. L.
97-219). CDC's SBIR program is under the stewardship of the Office of Science (OS). CDC is committed to ensuring a competitive award process that results in mission-relevant projects of scientific excellence and technological innovation with the potential for commercialization.
The Program's specific objectives are to: Stimulate technological innovation; Use small business to meet Federal R/R&D needs; Foster and encourage participation by emerging and undercapitalized SBCs in technological innovation and, Increase private sector commercialization of innovations derived from Federal R/R&D, thereby increasing competition, productivity and economic growth Eligible institutions/organizations Funding is awarded competitively and is available for only Phases I and II of the SBIR Program: Phase I contract awards up to $243,500 for approximately 6 months and Phase I grant awards up to $314,363* for project timeline that is typically 6 months (but may extend to 12 months) to support exploration of the technical merit or feasibility of an idea or technology.
Phase II awards projects that expand Phase I results. Awards can range up to $2,095,748* for a project period of up to 2 years. During this time, the R&D work is performed, and the developer evaluates commercialization potential.
Phase III is the period during which Phase II innovation moves from the laboratory into the marketplace. At this stage, the small business must find funding in the private sector or other non-SBIR federal agency funding. * CDC has a waiver from the Small Business Administration to exceed these budgets for CDC's Grant Topic Areas of Interest.
Applicants are strongly encouraged to contact CDC program officials early in the application planning process and before submitting any application in excess of the total award amounts listed above. CDC currently participates in SBIR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement ( PA-24-245 ) and SBIR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement ( PA-24-246 ).
See HHS Program Descriptions document pages 164-194 for CDC's research topics of interest. CDC participates along with the NIH in the PHS-2025-1 SBIR Contract Solicitation The contract solicitation receipt date was October 18, 2024, 5 p. m.
EDT. HHS held the Contract Solicitation Pre-proposal webinar (PHS-2025-1), on September 23, 2024, to discuss the PHS-2025-1 solicitation. SBIR report fraud, waste, and abuse What types of fraud are found in the SBIR Programs?
See Fraud, Waste, and Abuse details. Which SBIR rules should you become particularly familiar with? See Fraud, Waste, and Abuse details.
What happens if you break the rules? See Fraud, Waste, and Abuse details. For more information or to report wrongdoing HHS Small Business Innovation Research (SBIR) Fraud HHS OIG Hotline Operations Please direct all inquiries to: Office of Science, SBIR@cdc.
gov , or 404-718-1386. Technology Transfer Office ; Office of Science The Technology Transfer Office partners with industry, academia, non-profits, and other government agencies to improve public health.
According to the current listing, eligibility includes: U. S. -based small business concerns that meet specific criteria as described in the current SBIR parent funding opportunity announcements. Confirm the full requirements in the official notice before applying.
The current listing shows phase I up to $314,363; Phase II up to $2,095,748. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Innovation Research (SBIR) Program is funded by U.S. Department of Health and Human Services (HHS) / Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The August 31, 2026 award announcement splits $77 million across ten programs — $22.2 million to prevention, $23.6 million to treatment and recovery, $21.8 million to community mental health, $9.4 million to suicide and crisis. Read against the proposed consolidation of SAMHSA into the Administration for a Healthy America, the breakdown is a priorities map.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read articleThe HHS Grants Policy Statement that took effect October 1, 2025 raised the micro-purchase threshold to $50,000, the single audit threshold to $1 million, and the de minimis indirect cost rate to 15 percent — quietly rewriting the operational rules for tens of billions of dollars in annual awards. Combined with full 2 CFR Parts 200 and 300 adoption and new MAHA-aligned program priorities, it is the biggest compliance shift for health grantees since Uniform Guidance arrived in 2013.
Read article